Načítá se...
Phase II clinical trials with time-to-event endpoints: Optimal two-stage designs with one-sample log-rank test
Phase II clinical trials are often conducted to determine whether a new treatment is sufficiently promising to warrant a major controlled clinical evaluation against a standard therapy. We consider single-arm phase II clinical trials with right censored survival time responses where the ordinary one...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4013236/ https://ncbi.nlm.nih.gov/pubmed/24338995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.6073 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|